Benitec Biopharma Ltd ADR (BNTC) — Cash Flow Reinvestment Rate

Latest as of September 2018: 0.00x

Benitec Biopharma Ltd ADR (BNTC) has a Cash Flow Reinvestment Rate of 0.00x as of September 2018, reinvesting $26.00K (capex $26.00K ) from operating cash flow of $5.87 Million. Check BNTC operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

0.00x

(Capex + Investments) / Operating CF

Total Reinvested

$26.00K

Capex + Investments

Operating Cash Flow

$5.87 Million

USD

Capital Expenditures

$26.00K

USD

Benitec Biopharma Ltd ADR Cash Flow Reinvestment Rate (2019–2019)

Historical reinvestment intensity for Benitec Biopharma Ltd ADR across 1 annual periods. Explore Benitec Biopharma Ltd ADR debt service capacity to assess how comfortably operating cash covers total debt obligations.

Annual Cash Flow Reinvestment Rate for Benitec Biopharma Ltd ADR (2019–2019)

Year-by-year capital reinvestment analysis for Benitec Biopharma Ltd ADR. For live market cap and broader valuation context, see Benitec Biopharma Ltd ADR (BNTC) market capitalisation.

Year	Reinvestment Rate	Total Reinvested (USD)	Operating CF	Capex	YoY Change
2019	0.20x	$973.40K	$4.79 Million	$403.40K	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow